Format

Send to

Choose Destination
JAMA. 2016 Jul 19;316(3):271-2. doi: 10.1001/jama.2016.5998.

Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices.

Author information

1
Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
2
Division of Hematology Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland3Center for Health Care Ethics, Oregon Health & Science University, Portland.
PMID:
27149663
DOI:
10.1001/jama.2016.5998
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center